Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Glaxo Smith Kline

Monday 29 March 2010 19:00 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

On 19 March we reported on research by the Mayo Clinic into the finanical links of scientists involved in the debate about the diabetes drug Avandia. We should have made clearer that the research concerned the possibility of bias on the part of scientists who have written about Avandia and the need for higher rates of disclosure of financial conflicts of interest, rather than accusing GSK of improperly seeking to influence that debate. We are happy to reiterate, as stated in the article, that GSK is committed to greater transparency and to disclosure of financial links with clinicians.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in